There are 2789 resources available
466P - Landscape of HER2 alterations in 5786 Chinese patients with colorectal cancer
Presenter: Xiaoyun Li
Session: ePoster Display
467P - Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
Presenter: Eleonora Lai
Session: ePoster Display
468P - Prognostic role of aspartate aminotransferase-to-alanine aminotransferase ratio and lactate dehydrogenase levels in resectable colorectal cancer
Presenter: Ma Yifei
Session: ePoster Display
585P - Safety analysis of the phase III IPATential150 trial of ipatasertib (ipat) plus abiraterone (abi) in patients with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Cora Sternberg
Session: ePoster Display
586P - Safety of tazemetostat (TAZ) in combination with abiraterone/prednisone (A/P) or enzalutamide (E) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Wassim Abida
Session: ePoster Display
587P - Clinical and cost impact of cabazitaxel versus (vs) a second androgen receptor targeted agent (ARTA) for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel and the alternative ARTA (abiraterone or enzalutamide)
Presenter: Alicia Morgans
Session: ePoster Display
588P - Androgen changes after enzalutamide or abiraterone plus prednisone in men with castration-resistant prostate cancer (HEAT): Results from a randomised clinical trial
Presenter: Klara Kvorning Ternov
Session: ePoster Display
531P - Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial
Presenter: April Rose
Session: ePoster Display
469P - Potential emergent role of liquid biopsy in clinical practice in metastatic colorectal cancer (mCRC) treatment
Presenter: Valeria Zurlo
Session: ePoster Display
Resources:
Abstract
470P - Genomic landscape and its correlations with immunotherapy-related biomarkers in Chinese colorectal cancer patients
Presenter: Xiao Zheng
Session: ePoster Display
Resources:
Abstract